Perceptive Advisors is Buying Zogenix Inc. (NASDAQ:ZGNX) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Zogenix Inc. (NASDAQ:ZGNX) reported that Perceptive Advisors has picked up 1,355,302 of common stock as of 2017-02-22.
The acquisition brings the aggregate amount owned by Perceptive Advisors to a total of 1,355,302 representing a 5.46% stake in the company.
For those not familiar with the company, Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders in requirement of treatment alternatives. The Company’s areas of focus are epilepsy and schizophrenia. Its lead product candidate, ZX008, is a low-dose fenfluramine. The Company is also engaged in the development of Relday, which is a long-acting injectable formulation of risperidone indicated for the treatment of symptoms of schizophrenia and bipolar disorder in adults and teenagers 13 years of age and older. The Company is also engaged in manufacturing Sumavel DosePro (sumatriptan injection), a needle-free delivery system, which it sells to Endo Ventures Bermuda Limited and Endo Ventures Limited. Its DosePro technology is a drug delivery system designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle.
A glance at Zogenix Inc. (NASDAQ:ZGNX)’s key stats reveals a current market capitalization of 272.43 million based on 24.79 million shares outstanding and a price at last close of $10.66 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-12-15, Hawley picked up 10,000 at a purchase price of $13.74. This brings their total holding to 90,575 as of the date of the filing.
On the sell side, the most recent transaction saw Shively unload 19 shares at a sale price of $2.00. This brings their total holding to 358,771.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Zogenix Inc. (NASDAQ:ZGNX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Mfp Investors Llc. Picked Up Trinity Place Holdings Inc. (NYSEMKT:TPHS) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Trinity Place Holdings Inc. (NYSEMKT:TPHS) reported that Mfp Investors Llc. has picked up 3,670,577 of common stock as of 2017-02-22.
The acquisition brings the aggregate amount owned by Mfp Investors Llc. to a total of 3,670,577 representing a 12.5% stake in the company.
For those not familiar with the company, Trinity Place Holdings Inc. is a publicly traded vertically integrated real estate company focused on appropriate risk-adjusted real estate investments in the United States. The Company currently has over 500,000 square feet in active management and/or under development.
A glance at Trinity Place Holdings Inc. (NYSEMKT:TPHS)’s key stats reveals a current market capitalization of 240.15 million based on 25.49 million shares outstanding and a price at last close of $9.53 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-02-14, Mfp picked up 136,449 at a purchase price of 7.50. This brings their total holding to 3,670,577 as of the date of the filing.
On the sell side, the most recent transaction saw Marcato unload 6,300 shares at a sale price of $7.83. This brings their total holding to 4,198,570.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Trinity Place Holdings Inc. (NYSEMKT:TPHS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Deltic Timber Corp. (NYSE:DEL) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Deltic Timber Corp. (NYSE:DEL) reported that Southeastern Asset Management has picked up 1,827,558 of common stock as of 2017-02-22.
The acquisition brings the aggregate amount owned by Southeastern Asset Management to a total of 1,827,558 representing a 15.0% stake in the company.
For those not familiar with the company, Deltic Timber Corporation is a vertically integrated natural resources company. The Company is engaged in the growing and harvesting of timber and the manufacturing and marketing of lumber and medium density fiberboard (MDF). It operates through four segments: Woodlands, which manages all aspects of its timberlands, including harvesting and sale of timber, timberland sales and acquisitions, oil and gas revenues, timberland management and leasing of hunting land; Manufacturing, which consists of its approximately two sawmills that manufacture a range of softwood lumber products and the Del-Tin Fiber plant that produces MDF; Real Estate, which includes the Company’s approximately four real estate developments and a related country club operation, and Corporate, which consists of executive management and the staff functions. It is also engaged in real estate development in central Arkansas.
A glance at Deltic Timber Corp. (NYSE:DEL)’s key stats reveals a current market capitalization of 1.02 billion based on 12.16 million shares outstanding and a price at last close of $82.33 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-07, Nolan picked up 1,044 at a purchase price of $59.15. This brings their total holding to 89,341 as of the date of the filing.
On the sell side, the most recent transaction saw Walker unload 939 shares at a sale price of $79.54. This brings their total holding to 2,169.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Deltic Timber Corp. (NYSE:DEL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Shutterfly Inc. (NASDAQ:SFLY) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Shutterfly Inc. (NASDAQ:SFLY) reported that Park West Asset Management has picked up 2,106,324 of common stock as of 2017-02-22.
The acquisition brings the aggregate amount owned by Park West Asset Management to a total of 2,106,324 representing a 6.2% stake in the company.
For those not familiar with the company, Shutterfly, Inc. is a manufacturer and digital retailer of personalized products and services offered through a family of lifestyle brands. The Company offers a range of personalized photo-based products and services. The Company’s segments include Consumer, Enterprise and corporate. The Consumer segment sells the Company’s photo-based products, such as photo books, stationery and greeting cards, other photo-based merchandise, photo prints and also ships, as well as rents the BorrowLenses brand of products. The Enterprise segment is engaged in printing and shipping of direct marketing and other variable data print products and formats. The Company’s products and services are offered through a family of lifestyle brands, including Shutterfly, Tiny Prints, Wedding Paper Divas, ThisLife, MyPublisher and BorrowLenses. The Shutterfly brand includes photo books, announcements, as well as custom home decor products and photo gifts. The Shutterfly brand also includes online photo service.
A glance at Shutterfly Inc. (NASDAQ:SFLY)’s key stats reveals a current market capitalization of 1.61 billion based on 33.65 million shares outstanding and a price at last close of $47.18 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-02-12, Schoendorf picked up 15,000 at a purchase price of $44.71. This brings their total holding to 67,421 as of the date of the filing.
On the sell side, the most recent transaction saw Wiley unload 4,823 shares at a sale price of $47.35. This brings their total holding to 7,605.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Shutterfly Inc. (NASDAQ:SFLY) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Stamps.com Inc. (NASDAQ:STMP) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Stamps.com Inc. (NASDAQ:STMP) reported that Park West Asset Management has picked up 310,000 of common stock as of 2017-02-22.
The acquisition brings the aggregate amount owned by Park West Asset Management to a total of 310,000 representing a 1.8% stake in the company.
For those not familiar with the company, Stamps.com Inc. is a provider of Internet-based mailing and shipping solutions. The Company operates through the Internet Mailing and Shipping Services segment. Under the Stamps.com and Endicia branded solutions, the Company’s customers use its service to mail and ship a range of mail pieces, including postcards, envelopes, flats and packages, using a range of United States Postal Service (USPS) mail classes, including First Class Mail, Priority Mail, Priority Mail Express, Media Mail, and Parcel Select, and among others. Its customers include individuals, small businesses, home offices, medium-size businesses and large enterprises, and within these categories, the Company targets both mailers and shippers. In addition, the Company offers multi-carrier shipping solutions under the brand names ShipStation and ShipWorks. The Company’s products and services include Mailing and Shipping Business and Customized Postage.
A glance at Stamps.com Inc. (NASDAQ:STMP)’s key stats reveals a current market capitalization of 2.36 billion based on 17.05 million shares outstanding and a price at last close of $134.39 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-15, Jones picked up 10,000 at a purchase price of $113.15. This brings their total holding to 57,286 as of the date of the filing.
On the sell side, the most recent transaction saw Huebner unload 7,000 shares at a sale price of $130.76. This brings their total holding to 16,218.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Stamps.com Inc. (NASDAQ:STMP) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Advantis Corporation (OTCMKTS:ADVT) Rolls Out Cannabis Products for Pain Relief
Advantis Corporation (OTCMKTS:ADVT) shares rose 13.56% to $0.0335 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.03. The company has a market cap of $13.96 million at 465.48 million shares outstanding.
Advantis Corporation is a company that is focused on helping people take control of their health and pain management needs. It does this through partnerships innovative companies in the nutraceutical and alternative health care industries, making the company uniquely positioned to provide the guidance and support to assist in delivering products and services that address the needs of these individuals. Their strategy involves acquiring ownership in developing companies and providing consultation to improve product lines, expand distribution channels, and heighten brand value. Advantis concentrates on healthcare and pain management sectors that forecast staggering growth, identifying partners that possess the potential to capitalize on this trend.
In a press release yesterday, Advantis Corporation announced that it begins distribution of topical cannabis roll-on and Tinctures to treat pain conditions. In particular, Elixicure is a line of CBD dominant products used to treat pain without the psychoactive effects associated with THC. Its pain relief roll-onis specially formulated, using the extract of the cannabis plant, which contains the principal cannabinoid CBD while the pain cream includes over 90% Certified Organic ingredients and is specially formulated with Counter-Irritants to block pain receptors and Salicylic Acids to provide a deep penetrating Aspirin-like relief.
Elixicure utilizes the purest, pharmaceutically derived essential oils and active ingredients to create products that are superior in quality than those available in the marketplace today, and we are very excited to add them to our rapidly growing portfolio of products,” said Advantis Corporation CEO Christopher Swartz in a recent press conference.
The company has been on an all-out media blitz to provide exposure to deliver attention to their progress and product lines. They have also tapped UFC Legend Kimo Leopoldo as a brand ambassador since many high-profile fighters have been lobbying to make CBD remedies legal.
My passion for fighting has been a painful one. The day-to-day grind in the gym as well as the battles in The Octagon left me with aches and pains. The doctors prescribe medicines that may help with this pain, but the side effects from those medicines outweigh the benefits. The Elixicure line of products have relieved my pain with zero side effects,” said Kimo.
In a previous announcement CEO Swartz hinted that “revenue is about to explode” as the company has several efforts lined up for 2017. He added that the company is poised to reach its highest revenue ever for the year and that this momentum can be sustained in the foreseeable future.
We have seen the problem with chronic pain conditions increase exponentially and with that, opiate misuse and addiction as well. I have personally seen all this happen and have observed (too many times) people whom have lost hope,” Swartz further explained, “I have been passionate about creating solutions to effectively treat the masses without the negative side effects associated with opioids. Elixcure is the answer, and we are excited beyond belief to share this remedy with everyone in need.”
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.